{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:01:40Z","timestamp":1760781700382},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1999,1]]},"abstract":"<jats:p>\n            <jats:italic>Abstract<\/jats:italic>\n            \u2014There is a strong link between menopause and increased cardiovascular disease incidence in women, and observational studies suggest that postmenopausal hormone replacement therapy reduces cardiovascular disease risk by about half. Observational studies suffer from important limitations, however, and the only published prospective controlled trial of the effects of hormone replacement therapy on cardiovascular outcomes, the Heart Estrogen-Progestin Replacement Study (HERS), showed no net benefit of continuous estrogen plus synthetic progestin treatment in women with established coronary disease. Fundamental mechanistic studies of the cellular and molecular events by which hormones protect (or fail to protect) blood vessels from damage are needed to define the role of postmenopausal hormone replacement therapy in cardiovascular disease prevention. Most studies suggest that estrogen inhibits the neointimal response to acute injury in normal blood vessels, but this vasoprotective effect was not seen in vessels with preexisting atherosclerosis. Studies from our laboratory in the rat carotid injury model have shown that estrogen inhibits neointima formation via effects on all 3 layers of the vascular wall, including inhibition of medial smooth muscle cell migration and proliferation, stimulation of regrowth of endothelium, and inhibition of adventitial cell migration into neointima. Our laboratory is currently using transduced (lacZ) syngeneic fibroblasts as \u2018reporter\u2019 cells to delineate the factors that stimulate migration of adventitial cells into neointima after vascular injury and their modulation by estrogen and the other sex hormones. These fundamental studies will establish more rational strategies for therapeutic intervention in vascular diseases, including the basis for future gene therapy.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.33.1.170","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:53:46Z","timestamp":1339462426000},"page":"170-176","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":62,"title":["Hormones and Vasoprotection"],"prefix":"10.1161","volume":"33","author":[{"given":"Suzanne","family":"Oparil","sequence":"first","affiliation":[{"name":"From the Departments of Medicine and Physiology and Biophysics, University of Alabama at Birmingham, Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, University of Alabama at Birmingham."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.96.7.2468"},{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(95)00432-7"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-7435(91)90006-P"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420120047005"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608153350701"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)91300-S"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00306-3"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00443-3"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00351-8"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80409-3"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03420140097034"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008678"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.94.11.2982"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(98)00010-5"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.605"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.650"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)00078-0"},{"key":"e_1_3_1_18_2","first-page":"199","volume":"3","year":"1995","unstructured":"PEPI Trial Writing Group. Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. JAMA. 1995;3:199\u2013208.","journal-title":"JAMA"},{"key":"e_1_3_1_19_2","first-page":"R1022","volume":"261","year":"1991","unstructured":"Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 1991;261:R1022\u2013R1027.","journal-title":"Am J Physiol"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90184-8"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.91.7.1952"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0397-324"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0397-273"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.17.1.217"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0997-1005"},{"key":"e_1_3_1_26_2","first-page":"592","volume":"748","year":"1995","unstructured":"Orimo A, Inoue S, Ouchi Y, Orimo H. Vascular smooth muscle cells possess estrogen receptors and respond to estrogen. Ann N Y Acad Sci. 1995;748:592\u2013594.","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(95)02159-0"},{"key":"e_1_3_1_28_2","first-page":"139","volume":"191","year":"1995","unstructured":"Foegh ML, Zhao Y, Farhat M, Ramwell PW. Oestradiol inhibition of vascular myointimal proliferation following immune, chemical and mechanical injury. Ciba Found Symp. 1995;191:139\u2013145.","journal-title":"Ciba Found Symp"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00042-4"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.10.6.1051"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.89.4.8149515"},{"key":"e_1_3_1_32_2","first-page":"141","volume":"39","year":"1978","unstructured":"Clowes AW, Collazzo RE, Karnovsky MJ. A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat. Lab Invest. 1978;39:141\u2013150.","journal-title":"Lab Invest"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.90.5.7955204"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00279a011"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00231a027"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","unstructured":"Holt JT Radner RL Nienhuis AW. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol. 1988:963\u2013973.","DOI":"10.1128\/MCB.8.2.963"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.93.3.577"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.94.9.2221"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.95.5.1301"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.77.3.445"},{"key":"e_1_3_1_41_2","first-page":"327","volume":"49","year":"1983","unstructured":"Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle cell growth in the absence of endothelium. Lab Invest. 1983;49:327\u2013333.","journal-title":"Lab Invest"},{"key":"e_1_3_1_42_2","first-page":"208","volume":"49","year":"1983","unstructured":"Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208\u2013215.","journal-title":"Lab Invest"},{"key":"e_1_3_1_43_2","unstructured":"Thompson JA Li G Chen Y-F Oparil S. Estrogen inhibits migration of adventitial fibroblasts in vitro. In: Program and abstracts of the North American Vascular Biology Organization (NAVBO) April 15\u201318 1998; San Francisco Calif. Abstract 27."},{"key":"e_1_3_1_44_2","first-page":"1655","volume":"4","year":"1996","unstructured":"Shi Y, O\u2019Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;4:1655\u20131664.","journal-title":"Circulation"},{"key":"e_1_3_1_45_2","first-page":"340","volume":"3","year":"1996","unstructured":"Shi Y, Pieniek M, Fard A, O\u2019Brien JE, Mannion JD, Zalewski A. Adventitial remodeling following coronary arterial injury. Circulation. 1996;3:340\u2013348.","journal-title":"Circulation"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.95.4.997"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.90.2.8044966"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117240"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117123"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.2.654"},{"key":"e_1_3_1_51_2","first-page":"418","volume":"49","year":"1950","unstructured":"Saphir O, Gore I. Evidence for an inflammatory basis of coronary arteriosclerosis in the young. Arch Pathol. 1950;49:418\u2013426.","journal-title":"Arch Pathol"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.71.4.709"},{"key":"e_1_3_1_53_2","first-page":"835","volume":"135","year":"1989","unstructured":"Prescott MF, McBride CK, Court M. Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol. 1989;135:835\u2013846.","journal-title":"Am J Pathol"},{"key":"e_1_3_1_54_2","first-page":"201","volume":"2","year":"1992","unstructured":"Beesley JE, Honey AC, Martin JF. Ultrastructural assessment of lesion development in the collared rabbit carotid artery model. Cells and Materials. 1992;2:201\u2013208.","journal-title":"Cells and Materials"},{"key":"e_1_3_1_55_2","unstructured":"Li G Chen YF Oparil S Thompson JA. Estrogen indirectly inhibits adventitial fibroblast migration. Circulation. 1998 (AHA abstract-accepted for publication). In press."},{"key":"e_1_3_1_56_2","unstructured":"Li G Chen S-J Chen Y-F Durand J Thompson JA Oparil S. Adventitial fibroblasts contribute to neointima formation in balloon injured rat carotid arteries. Circulation 1998;98(suppl I):I-182. Abstract 940."}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.33.1.170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T17:38:16Z","timestamp":1715535496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.33.1.170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1161\/01.HYP.33.1.170"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.33.1.170","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]},"assertion":[{"value":"1999-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}